semaglutide news october 20 2025 Oral Wegovy approved for obesity management by FDA on December 23, Formulation: High‑dose oral (25 mg daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) FDA declares end to Wegovy

Chronic Heart Failure Song et al

Melo van Lent D, O'Donnell A, Beiser AS, et al

Understanding which foods work best with semaglutide or following a structured tirzepatide-specific diet plan can make a significant difference in both how you feel and how much weight you lose

"Double the dose of these types of drugs is a massive difference it shows the market cannot be taken at face value," Mr Bonenti said

The agency also warned companies about misleading claims about safety and effectiveness

What the Maintenance Program Includes Customized dosing adjustments based on your current progress Regular consultations with our medical team (in-person or virtual) Access to ongoing health coaching and support Guidance on maintaining healthy habits post-weight loss Why Continue with Maintenance